TnT Human

Cardiac Troponin T Human
Shipped with Ice Packs
In Stock

Description

Human Cardiac Troponin T produced from Human Cardiac Tissue, having a molecular weight of approximately 35 kDa.
The Cardiac troponin-T is purified using a combination of ion-exchange and affinity chromatography steps.

Product Specs

Introduction
Troponin-T (TnT) is a protein central to the contraction of striated muscle. Specifically, cardiac troponin-T (TnTc) is exclusively found in heart muscle and is a highly specific biomarker for heart disease. TnTc is one part of a three-part complex, troponin, which regulates muscle contraction in response to changes in calcium ion concentration. Mutations in the gene that codes for TnTc, TNNT2, are linked to heart conditions like familial hypertrophic cardiomyopathy and dilated cardiomyopathy. The body can produce slightly different forms of TnTc through a process called alternative splicing, leading to variations of the protein in different tissues.
Description
This product consists of human cardiac troponin T, purified from human cardiac tissue. It has a molecular weight of roughly 35 kDa and is prepared through a multi-step process involving ion-exchange and affinity chromatography to ensure its purity.
Physical Appearance
This product appears as a clear, colorless liquid solution that has been sterilized by filtration.
Formulation
This product is provided as a 1.95 mg/ml solution of human cardiac troponin T in a buffer consisting of 6M Urea, 250mM NaCl, 50mM Tris-HCl, 15mM b-mercaptoethanol, 1mM EDTA, at a pH of 7.2.
Stability
For optimal long-term storage, it is recommended to store human TnT below -18°C. While it can remain stable at 10°C for up to 7 days, repeated freezing and thawing should be avoided.
Purity
The purity of this product is greater than 98.0%, as determined by SDS-PAGE analysis.
Synonyms
Troponin T cardiac muscle, TnTc, Cardiac muscle troponin T, cTnT, TNNT2, CMH2, CMPD2, MGC3889.
Source
Human Cardiac Tissue.

Q&A

What are the two primary TNT systems relevant to human research?

In scientific literature, "TNT" primarily refers to two distinct research domains with significant human applications:

  • Tunneling Nanotubes (TNTs): These are tubular membrane nanostructures that facilitate direct intercellular communication over distances of 10–200 μm. TNTs can range in diameter from 5 to 1,000 nm and allow for the transfer of various intracellular components between connected cells .

  • Think/No-Think (TNT) Task: This is a cognitive psychology paradigm developed to investigate memory control and its neural underpinnings. The task has been in use for approximately 20 years and includes three phases: learning phase, TNT phase, and recall phase .

Each system provides critical insights into human biological or cognitive processes and employs distinct methodological approaches.

How does TNT research apply to human disease contexts?

Tunneling nanotubes play significant roles in multiple human pathologies:

  • Cancer progression: TNTs facilitate the transfer of oncogenic molecules between cancer cells, contributing to tumor growth, metastasis, and therapy resistance. They also enable communication between cancer cells and non-tumoral cells in the microenvironment .

  • Neurodegenerative disorders: TNTs contribute to disease progression by enabling the spread of pathological proteins like α-synuclein mis-folds and aggregates implicated in Parkinson's disease .

  • Viral infections: Viruses including HIV, herpes simplex virus, and respiratory syncytial virus exploit TNTs for intercellular transfer and host tissue dissemination .

  • Vascular conditions: TNTs are implicated in human brain vascularization, tumoral neo-angiogenesis, and cardiovascular diseases such as atherosclerosis and cardiac ischemia-reperfusion injury .

In cognitive research, the Think/No-Think paradigm helps understand memory control mechanisms that may be relevant to conditions involving intrusive thoughts, such as post-traumatic stress disorder and depression .

What are the fundamental components of TNT structures in human cells?

Recent research has identified several key structural components of tunneling nanotubes in human cells:

Structural ComponentCell TypeFunction in TNTsReference
Glial Fibrillary Acid Protein (GFAP)Glioblastoma cellsKey structural protein that interacts with mitochondria during intercellular transfer
Cytokeratin 7Urothelial cellsComponent of TNTs in both normal and cancer cells
SeptinsVariousSupport membrane reshaping and interact with other cytoskeletal elements
Actin filamentsVariousPrimary cytoskeletal component
MicrotubulesVariousStructural support and transport

The tri-cytoskeletal composition (combining elements of actin filaments, microtubules, and intermediate filaments) provides TNTs with both structural stability and the elasticity needed for their function .

How should researchers design experiments to investigate TNTs in human tissues?

Investigating tunneling nanotubes in human tissues requires a multi-faceted approach:

  • Integrated model systems: Combine in vitro, ex vivo, and in vivo models to develop a comprehensive understanding. Each model offers unique advantages that, when integrated, can provide a detailed and clinically relevant picture .

  • Advanced imaging: Employ high-resolution microscopy techniques such as electron microscopy and super-resolution microscopy, while acknowledging their limitations due to the fragile and transient nature of TNTs .

  • Co-culture models: Establish systems that reflect the complex microenvironment, such as the urothelial cancer-normal co-culture model described by Resnik et al., which helps investigate the role of TNTs in cancer progression and recurrence .

  • Mechanical property assessment: Implement methods to evaluate the physical and elastic properties of TNTs, which is particularly important for developing therapeutic strategies based on TNT manipulation .

  • Interdisciplinary integration: Combine bioinformatics and computational modeling with experimental approaches to predict TNT behavior in cellular networks .

Gene-editing technologies like CRISPR/Cas9 can be used to manipulate genes involved in TNT formation and function, providing insights into their biological roles .

What protocols should be followed when implementing the Think/No-Think task in human studies?

The implementation of a Think/No-Think task requires careful attention to multiple methodological elements:

  • Task structure: Maintain the three-phase structure (learning, TNT, recall) while ensuring appropriate timing. The whole experiment typically takes about 1 hour for the behavioral version and 1.5 hours for the fMRI version .

  • Stimulus selection: Choose appropriate stimuli for your research question. While word pairs were traditionally used, pictorial material like object-scene or face-scene pairs have become more common in recent studies, offering greater ecological validity .

  • Critical instructions for participants: During No-Think trials, participants must:

    • Look at and attend to the Hint

    • Prevent the associated Response from coming to mind

    • Actively push out the Response if it does emerge

    • Avoid replacing the Response with anything else (to prevent thought substitution)

    • Process the reminder "holistically"

  • Structure optimization: Include adequate practice trials with diagnostic questionnaires to ensure participant understanding and compliance. Organize the TNT phase into blocks (typically 4-5) with short breaks to maintain attention and focus .

  • Variant selection: Consider the specific variant needed for your research question. For example, the "waiting for the urge to suppress" procedure might be more appropriate for studying active inhibitory mechanisms .

Clear instructions and careful participant training are essential for reliable results in TNT task implementation .

How can researchers address the challenges of identifying TNTs in heterogeneous human tissues?

The identification of tunneling nanotubes in human tissues presents significant challenges that require sophisticated approaches:

  • Marker development strategies: Despite two decades of research, no universal marker for TNTs has been identified. This is because the molecular, structural, and biophysical identity of TNTs is highly diverse and context-dependent. Researchers should adopt a multi-marker approach, potentially focusing on cytoskeletal components that appear more consistently in TNTs across cell types .

  • Tissue complexity considerations: The complex three-dimensional arrangement of cells in tissues makes TNT identification particularly challenging in vivo. Advanced tissue clearing techniques combined with super-resolution microscopy may help overcome this limitation .

  • Technical adaptations: Given the fragility of TNTs, standard fixation and processing methods can disrupt these structures. Live-cell imaging with minimal manipulation is preferable, but when not possible, specialized gentle fixation protocols should be employed .

  • Functional validation: Since morphological identification alone is insufficient, researchers should complement structural observations with functional studies demonstrating intercellular transfer of cargo .

  • Computational assistance: Machine learning algorithms can be trained to identify TNT-like structures in complex tissue images, potentially increasing detection accuracy and throughput .

The challenge remains significant, and addressing it will likely require collaborative efforts across disciplines to develop new technical approaches specifically designed for TNT visualization in intact tissues.

What mechanisms govern the regulation of TNT formation in human diseases?

The regulation of tunneling nanotube formation in disease contexts involves complex cellular mechanisms:

Regulatory FactorMechanismDisease ContextReference
Microenvironment stressHypoxia, nutrient deprivation, and inflammatory signals can trigger TNT formationCancer, cardiovascular disease
Cytoskeletal dynamicsActin polymerization and microtubule stability influence TNT elongation and maintenanceMultiple diseases
Membrane reshaping proteinsSeptins and associated proteins facilitate membrane curvature needed for TNT formationCancer progression
ESCRT complexEndocytic-sorting complex required for transport affects membrane remodelingViral spread
Intermediate filament proteinsGFAP in glioblastoma and cytokeratin 7 in urothelial cancer contribute to TNT stabilityCancer-specific regulation

Understanding these regulatory mechanisms provides potential targets for therapeutic intervention. For example, inhibitors of actin polymerization could potentially disrupt TNT formation in disease contexts where TNTs contribute to pathology. Alternatively, the intercellular communication facilitated by TNTs could be exploited for drug delivery, as TNTs can transfer nanoparticles between connected cells .

How do we account for individual differences in memory suppression ability in Think/No-Think studies?

Individual differences in memory suppression present a significant challenge in Think/No-Think research:

  • Conditionalization procedures: To account for initial learning differences, analysis should be conditionalized on successful initial learning. This involves including only those items that participants successfully learned during the criterion test in the final analysis .

  • Intrusion measurement refinement: Implementing intrusion ratings during the TNT phase can provide a more nuanced understanding of suppression ability. Participants can report whether the associated memory entered awareness during No-Think trials, allowing researchers to track suppression success dynamically .

  • Cognitive style assessment: Measuring participants' tendencies toward thought substitution versus direct suppression can help account for strategy differences. Some individuals naturally favor replacement strategies over inhibitory control .

  • Neuroimaging correlates: Individual differences in suppression ability correlate with activation patterns in the prefrontal cortex and its connectivity with memory-related regions. Incorporating these neuroimaging measures can help characterize suppression capacity .

  • "Waiting for the urge" methodology: For participants who show minimal suppression effects, implementing the "waiting for the urge to suppress" variant may be more effective, as it ensures that suppression is triggered by an active memory trace .

These approaches allow researchers to better characterize the complex nature of memory control abilities and potentially identify specific deficits in clinical populations.

How might TNT research methodologies be combined for translational impact?

The integration of both TNT research domains could lead to innovative translational approaches:

  • Merged imaging platforms: Developing systems that simultaneously track cognitive control processes (using Think/No-Think paradigms) while visualizing cellular communication (via tunneling nanotube monitoring) could reveal how cognitive processes influence cellular behavior in stress-responsive tissues .

  • Disease progression models: Combining knowledge of how TNTs facilitate disease spread with cognitive control abilities could help identify individuals at risk for rapid disease progression and develop targeted interventions .

  • Therapeutic targeting strategies: Insights from cognitive TNT research on suppression mechanisms could inform approaches to disrupt pathological TNT-mediated communication, particularly in conditions where both cognitive and cellular processes are dysregulated .

  • Biomarker development: Correlating TNT formation tendencies with cognitive suppression abilities could potentially yield novel biomarkers for conditions like stress-related disorders or neurodegenerative diseases .

Such integrative approaches would require multidisciplinary teams combining expertise in cellular biology, cognitive neuroscience, and clinical research, but could substantially advance our understanding of mind-body connections in health and disease.

What are the most promising therapeutic targets derived from TNT research?

Research on tunneling nanotubes has identified several promising therapeutic approaches:

  • Disruption strategies: Inhibitors of actin polymerization could be used to disrupt TNT formation in diseases where TNTs contribute to pathology, such as cancer metastasis or viral spread .

  • Exploitation approaches: The natural intercellular transfer capability of TNTs could be harnessed for targeted drug delivery, particularly for delivering nanoparticles between connected cells .

  • Structural targeting: Intermediate filament proteins such as GFAP in glioblastoma cells or cytokeratin 7 in urothelial cancer cells represent potential TNT-specific targets that could be manipulated to control disease spread .

  • Mechanical intervention: Given the elasticity and physical properties of TNTs, mechanical disruption methods could potentially be developed to selectively break these connections in disease contexts .

In cognitive research, the Think/No-Think paradigm may inform therapeutic approaches for conditions characterized by intrusive thoughts, such as post-traumatic stress disorder or obsessive-compulsive disorder. Understanding how memory suppression can be enhanced or trained could lead to cognitive interventions that strengthen these abilities in vulnerable populations .

How do we reconcile contradictory findings in TNT research literature?

Addressing contradictions in TNT research requires methodological rigor and careful interpretation:

  • Standardization efforts: For Think/No-Think research, standardized protocols and training materials have been developed to increase reliability and replicability across laboratories. Similar standardization for tunneling nanotube research could help resolve contradictory findings .

  • Context-specific considerations: The molecular, structural, and biophysical identity of tunneling nanotubes varies greatly depending on the cellular environment. Seemingly contradictory findings may reflect genuine biological diversity rather than methodological inconsistency .

  • Mechanism-based reconciliation: In Think/No-Think research, failures to replicate suppression effects may be explained by the "waiting for the urge to suppress" hypothesis, which suggests that true inhibitory control only occurs when there is an active memory to suppress .

  • Technical limitations awareness: High-resolution microscopy techniques required for TNT visualization have inherent limitations due to the fragile nature of these structures. Technical differences between studies may explain apparently conflicting results .

  • Interdisciplinary integration: Combining bioinformatics, computational modeling, and experimental approaches can help develop more comprehensive theoretical frameworks that accommodate apparently contradictory findings .

By addressing these considerations, researchers can build a more coherent understanding of both TNT domains, ultimately advancing their application in human health and disease contexts.

Product Science Overview

Introduction

Cardiac Troponin T (cTnT) is a protein that plays a crucial role in the contraction of cardiac muscle. It is part of the troponin complex, which also includes troponin I and troponin C. This complex is essential for the regulation of muscle contraction in both skeletal and cardiac muscles. However, the cardiac-specific isoform of troponin T is particularly significant in the context of heart health and disease.

Discovery and Significance

Cardiac Troponin T was discovered by the German physician Hugo A. Katus at the University of Heidelberg . He also developed the troponin T assay, which has become a vital tool in the diagnosis of myocardial infarction (heart attack). The presence of elevated levels of cTnT in the bloodstream is a key indicator of cardiac muscle damage, making it an invaluable biomarker for diagnosing acute coronary syndromes .

Structure and Function

The troponin complex, including cTnT, is responsible for coupling the sarcomere contraction cycle to variations in intracellular calcium concentration . Troponin T binds to tropomyosin, helping to position it on actin filaments, and together with the rest of the troponin complex, modulates the contraction of striated muscle . This regulation is crucial for the proper functioning of the heart, as it ensures that the heart muscle contracts and relaxes in a coordinated manner.

Clinical Relevance

The measurement of cTnT levels in the blood is a cornerstone in the diagnosis of myocardial infarction. Elevated levels of cTnT are indicative of cardiac muscle injury, which can occur due to various conditions, including heart attacks, heart failure, and other forms of cardiac stress . The development of high-sensitivity assays for cTnT has further enhanced its diagnostic utility, allowing for the detection of even minor cardiac injuries .

Research and Future Directions

Ongoing research continues to explore the various roles and mechanisms of cTnT in cardiac health and disease. Understanding the precise pathways and interactions involving cTnT can lead to improved diagnostic methods and potential therapeutic targets for cardiac conditions . Additionally, the use of cTnT as a prognostic marker in chronic diseases and its potential role in non-cardiac conditions are areas of active investigation .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.